We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
-9.72%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$6.67B
AUM Growth
-$658M
Cap. Flow
+$79.2M
Cap. Flow %
1.19%
Top 10 Hldgs %
57.1%
Holding
295
New
64
Increased
76
Reduced
63
Closed
70

Top Buys

Rank Stock Value
1
FRPT icon
Freshpet
FRPT
+$87.7M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$59.2M
3
STAA icon
STAAR Surgical
STAA
+$42.7M
4
KDP icon
Keurig Dr Pepper
KDP
+$35.7M
5
SNN icon
Smith & Nephew
SNN
+$34.1M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$81.1M
2
NARI
Inari Medical, Inc. Common Stock
NARI
+$79.9M
3
GSK icon
GSK
GSK
+$73.2M
4
HUM icon
Humana
HUM
+$69.2M
5
BUD icon
AB InBev
BUD
+$68M

Sector Composition

Rank Sector Weight
1 Healthcare 35.45%
2 Consumer Discretionary 6.85%
3 Consumer Staples 5.47%
4 Technology 5.39%
5 Communication Services 1.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
APCXW
201
DELISTED
AppTech Payments Corp Warrant
APCXW
$127K ﹤0.01%
715,000
– –
PALI icon
202
Palisade Bio
PALI
$363M
$98.6K ﹤0.01%
144,764
+39,397
+37% +$46.6K
ONFOW icon
203
Onfolio Holdings Warrant
ONFOW
$75.1K
$92K ﹤0.01%
400,000
– –
WLDS icon
204
Wearable Devices
WLDS
$9.28M
$87.2K ﹤0.01%
5,183
+16
+0.3% +$558
VTAK icon
205
Catheter Precision
VTAK
$977K
$86.3K ﹤0.01%
13,209
+6,411
+94% +$48.5K
MOBBW
206
Mobilicom Ltd Warrants
MOBBW
$2.39B
$78.5K ﹤0.01%
242,100
– –
LCFYW icon
207
Locafy Ltd Warrant
LCFYW
$72.6K ﹤0.01%
12,121
– –
AYTU icon
208
AYTU BioPharma
AYTU
$25M
$69.1K ﹤0.01%
57,597
-92,403
-62% -$134K
SQFTW icon
209
Presidio Property Trust Inc Series A Warrants
SQFTW
$198K
$68.6K ﹤0.01%
2,000,000
– –
NXLIW
210
DELISTED
Nexalin Technology Inc Warrant
NXLIW
$57.4K ﹤0.01%
325,000
– –
NXTC icon
211
NextCure
NXTC
$22.7M
$50K ﹤0.01%
8,667
– –
FGIWW
212
FGI Industries Warrant
FGIWW
$225K
$46.6K ﹤0.01%
933,333
– –
MDCXW
213
Medicus Pharma Warrant
MDCXW
$429K
$42.4K ﹤0.01%
+60,600
New +$62.8K
BIAFW icon
214
bioAffinity Technologies
BIAFW
$38.8K ﹤0.01%
204,082
– –
HSDT icon
215
Solana Company
HSDT
$98.1M
$28.9K ﹤0.01%
+96
New +$40.7K
SHPH icon
216
Shuttle Pharmaceuticals
SHPH
$2.56M
$27.4K ﹤0.01%
282
-942
-77% -$153K
PCSA icon
217
Processa Pharmaceuticals
PCSA
$6.37M
$20.7K ﹤0.01%
+2,240
New +$33.7K
RVSNW icon
218
Rail Vision Ltd Warrant
RVSNW
$736K
$12.2K ﹤0.01%
136,187
– –
SWAGW icon
219
Stran & Company Warrant
SWAGW
$91.1K
$5.56K ﹤0.01%
545,000
– –
IVDAW icon
220
Iveda Solutions Warrant
IVDAW
$53.9K
$2.65K ﹤0.01%
18,125
– –
BCTXW
221
DELISTED
BriaCell Therapeutics Corp Warrant
BCTXW
$2.55K ﹤0.01%
25,000
-350,000
-93% -$48.5K
KTTAW icon
222
Pasithea Therapeutics Warrants
KTTAW
$21.4K
$910 ﹤0.01%
50,000
– –
BNCWW
223
CEA Industries Inc Warrant
BNCWW
$44.7K
$852 ﹤0.01%
58,333
– –
TNONW icon
224
Tenon Medical Inc Warrant
TNONW
$1.49K
$456 ﹤0.01%
22,250
– –
NLSPW
225
DELISTED
NLS Pharmaceutics Warrant
NLSPW
$161 ﹤0.01%
12,500
– –
7 8
9
10 11

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
ACM
Altimeter Capital Management Boston, Massachusetts $5.7B AUM 36.74% 1-Year Est. Return
PI
PGGM Investments Zeist, Netherlands $5.7B AUM 17.05% 1-Year Est. Return

Armistice Capital's Q1 2025 Portfolio in Review

As of Q1 2025, Armistice Capital held 295 positions worth $6.67B, down 9% from $7.33B the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Armistice Capital's Q1 2025 filing shows 64 new, 76 increased, 63 reduced and 70 closed positions. Its largest new stake was Freshpet: 716,960 shares worth $59.6M. The largest sale was Vertex Pharmaceuticals, an estimated $81.1M.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, down from 39% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

  • Armistice Capital's largest Q1 2025 buy was Freshpet: 716,960 shares worth $59.6M.
  • Armistice Capital added most to Regeneron Pharmaceuticals in Q1 2025, an estimated $59.2M increase.
  • Armistice Capital's biggest Q1 2025 reduction was Vertex Pharmaceuticals, cutting an estimated $81.1M.
  • Armistice Capital fully exited Inari Medical, Inc. Common Stock in Q1 2025, selling an estimated $79.9M.
  • Armistice Capital's ten largest holdings make up 57% of its $6.67B portfolio in Q1 2025.
  • Armistice Capital opened 64 new positions and closed 70 in Q1 2025.
  • Armistice Capital's portfolio value fell 9% quarter-over-quarter to $6.67B.

Based on Armistice Capital's 13F filing for Q1 2025, filed 15 May 2025.